Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02LCI
|
||||
Former ID |
DIB014643
|
||||
Drug Name |
TA-5493
|
||||
Synonyms |
P38 inhibitor (rheumatoid arthritis/ psoriasis), Mitsubishi Tanabe
|
||||
Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Discontinued in Phase 1 | [548178] | ||
Company |
Tanabe Seiyaku Co Ltd
|
||||
Target and Pathway | |||||
Target(s) | Stress kinase p38 | Target Info | Inhibitor | [550897] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.